DCGI asks manufacturers to take steps to prevent black-marketing, overpricing of COVID-19 drugs
https://ift.tt/2ZG7E7s
In order to prevent black-marketing and overpricing of COVID-19 drugs such as Remdesivir, India's drugs regulator DCGI has asked manufacturers to set up a helpline for patients and also put on their websites details of distributors and supply chain.
In order to prevent black-marketing and overpricing of COVID-19 drugs such as Remdesivir, India's drugs regulator DCGI has asked manufacturers to set up a helpline for patients and also put on their websites details of distributors and supply chain.
No comments